Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_assertion type Assertion NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_head.
- NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_assertion description "[PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_provenance.
- NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_assertion evidence source_evidence_literature NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_provenance.
- NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_assertion SIO_000772 7749407 NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_provenance.
- NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_assertion wasDerivedFrom befree-20150227 NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_provenance.
- NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_assertion wasGeneratedBy ECO_0000203 NP605687.RA3K44bnXZAeUXM5a4uubyVRBzsDR9IhyCHcnEdSzkj9Q130_provenance.